Table 2 Pathological features and outcomes of elderly AGC patients who underwent distal gastrectomy

 Site

0.10

  Pylorus or antrum

70

(92)

32

(86)

38

(97)

  Low body

6

(7.9)

5

(14)

1

(2.6)

 Size (cm)

5.0

(3.22–6.5)

5.5

(4–7)

4.5

(3.15–6)

0.10

 Bormann type

0.075

  Early gastric cancer

1

(1.3)

0

(0)

1

(2.6)

  I or II

17

(22)

5

(14)

12

(31)

  III or IV

58

(76)

32

(86)

26

(67)

 Lauren classification

0.99

  Intestinal type

56

(74)

28

(76)

28

(72)

  Diffuse type

12

(16)

5

(14)

7

(18)

  Mixed type

8

(11)

4

(11)

4

(10)

 Cell differentiation

0.70

  Well differentiated

8

(11)

4

(11)

4

(10)

  Moderately differentiated

39

(51)

17

(46)

22

(56)

  Poorly or undifferentiated

29

(38)

16

(43)

13

(33)

 LN metastasis (number)

4

(1–8)

5

(1–10)

4

(2–8)

0.90

 LN harvested (number)

39

(29–48)

42

(29–52)

37

(30–45)

0.30

 Lymphovascular invasion

53

(70)

26

(70)

27

(69)

0.99

 Perineural invasion

39

(51)

25

(68)

14

(36)

0.007*

 Pathological T stage (AJCC 8th)

0.5

  1

5

(6.6)

1

(2.7)

4

(10)

  2

15

(20)

6

(16)

9

(23)

  3

34

(45)

18

(49)

16

(41)

  4

22

(29)

12

(32)

10

(26)

 Pathological N stage (AJCC 8th)

0.20

  0

10

(13)

7

(19)

3

(7.7)

  1

17

(22)

7

(19)

10

(26)

  2

23

(30)

8

(22)

15

(38)

  3

26

(34)

15

(41)

11

(28)

Pathological stage (AJCC 8th)

0.8

  II

36

(47)

17

(46)

19

(49)

  III

40

(53)

20

(54)

20

(51)

 Operative time (min)

206

(178–228)

192

(165–212)

215

(190–238)

0.006*

 Blood loss (mL)

100

(0–200)

100

(0–200)

100

(0–150)

0.059

 Complications (≥ grade 3)

10

(13)

5

(14)

5

(13)

0.99

 Length of postoperative hospitalization (d)

12

(10–16)

13

(11–22)

11

(10–14.5)

0.042*

 Follow-up (mo)

22

(12–38)

27

(15–44)

15

(10–32)

0.03*

 Three-year RFS (%)

58.6

(47.9–71.7)

51.0

(37.1–70.1)

66.2

(51.1–85.7)

0.10